|
 |
Dai D. Nghiem, M.D.
Principal hospital base:
Allegheny General Hospital
Current professional and academic appointments (Include starting date):
| 2004 - present: |
|
Attending Surgeon, Veteran Administration hospital, Pittsburgh, PA |
| 2004 - present: |
|
Director, Division of Transplant Surgery, Allegheny General Hospital |
| 1986 - 2004: |
|
Head, Transplantation Services, Allegheny General Hospital |
| 1992 - present: |
|
Professor of Surgery, Drexel University College of Medicine (formerly MCP Hahnemann) (with tenure) |
Undergraduate medical education (including dates and degrees):
| 1960 - 1969: |
|
M.D., Saigon Medical School, Saigon, Vietnam "Interne des Hospitaux" of Saigon |
Postgraduate medical education (including dates of internships, residencies, fellowships, etc.):
| 1973 - 1974: |
|
Surgery Residency, University of Pittsburgh, Pittsburgh, PA |
| 1974 - 1977: |
|
Surgery Residency, University of Arkansas, Little Rock, AK |
| 1977 - 1978: |
|
Surgery Residency, West Virginia University, Charleston, WV |
| 1978 - 1980: |
|
Fellow, Medical College of Virginia, Richmond, VA |
BASIC RESEARCH
| Project: |
|
CMV treatment in Transplantation Registry (February 1998 - December 1999). |
| Funding source: |
|
Sangstat Pharmaceutical Company |
|
| Project: |
|
A three-year, randomized multi-center, double blind, double dummy, parallel group study SDZ. RAD tablets versus mycophenolate mofetil as part of triple immunosuppression therapy in de novo renal transplant patients (1998-2002). |
| Funding source: |
|
Roche |
|
| Project: |
|
An open - label, multicenter study to further characterize the clinical utility and safety of Rapamune® and cyclosporine combination treatment in DeNovo renal allografts recipients. (1999-2002). |
| Funding source: |
|
Roche |
|
| Project: |
|
A comparative open-label study to evaluate graft function in De Novo renal allograft recipient treated with either a reduced dose or a standard dose of Cyclosporin in combination with Rapamune and Corticosteroid (2000-2002). |
| Funding source: |
|
Roche |
|
| Project: |
|
Open-label, prospective, randomized, multicenter, phase II comparative trial of Thymoglobulin® versus Simulect™ for the prevention of delayed graft function and acute allograft rejection in renal allograft recipients. (2000-2002). |
| Funding source: |
|
Sangstat Pharmaceutical Company |
CLINICAL RESEARCH
| Retrospective reviews: |
|
Disseminated Intravascular Coagulopathy in Kidney Transplants. |
| Funding source: |
|
None |
|
| Therapeutic interventions: |
|
Steroid Free Immunosuppression |
| Funding source: |
|
None |
Recent publications and presentations:
Peer-reviewed publications (i.e., journal articles)
Nghiem DD, Gignac MR, Marcus RD, Hsia S, Schlosser JD. Mycophenolate mofetil reduces late renal allograft loss: a 4-year study. Transplant Proc. 2002 Aug;34(5):1683-4.
Sureshkumar KK, Mubin T, Mikhael N. Kashif MA, Nghiem DD, Marcus RJ. Assessment of quality of life after simultaneous pancreas-kidney transplantation. Am J Kidney Dis. 2002 Jun;39(6)1300-6.
Hsu TH, Gill IS, Grune MT, Anderson R. Eckhoff D, Goldfarb DA, Gruessner R, Hodge EE, Munch LC, Nghiem DD, Nye A, Reckard CR, shaver T, Stratta RJ, Taylor RJ. Laparoscopic lymphocelectomy: a multi-institutional analysis. J Urol. 2000 Apr;163(4):1096-8.
Nghiem DD, Schlosser JD, Nghiem HG. Ten-year experience with infant kidneys transplanted en bloc. Transpl Int. 1998;11 Suppl 1:S35-8.
Nghiem DD, Schlosser JD, Hsia S. Nghiem HG. En bloc transplantation of infant kidneys: ten-year experience. J Am Coll Surg. 1998 Apr;186(4):402-7.
Sureshkumar KK, Nghiem DD. Use of mycophenolate mofetil in immunosuppressive protocols in elderly renal transplant recipients. Transplantation. 2003 Jul 27;76(2):441-2
Nghiem DD. Graft survival... Transplantation. Transplantation 2003 Jun 27;75(12):2158-9
Nghiem DD. Role of pharmacologic enhancement of p-450 in cyclosporine overdose. Transplantation 2002 Nov 15;74(9):1355-6
Nghiem DD. Low absolute glomerular filtration rates in the living kidney donor: a risk factor for graft loss. Transplantation 2001 Oct 27;72(8):1465-6.
Nghiem DD. Arterialization of portal conduit in pancreas transplantation. Transpl Int. 2001;14(1):58-9.
Nghiem DD. Use of grafts procured from transplant recipients. Transplantation. 2000 Mar. 5;69(5):1026.
Nghiem DD. "Chronic renal artery occlusion: nephrectomy versus revascularization." J Vasc Surg. 2000 Feb;31(2):411-2.
Nghiem DD. "Right atrial bypass grafting for central venous obstruction associated with dialysis access: another treatment option." J Vasc surg. 1999 Sep;30(3):582-4.
Nghiem DD. Impotence after renal transplantation. Transplantation. 1998 Oct 15;66(7):938-9.
Nghiem DD, Hsia S, Schlosser JD, Nghiem HG. Delayed endocrine graft function: truth or myth? Transplant Proc. 1998 Mar;30(2):284.
International/national/regional presentations
"Nephron Dosing: Double Adult Kidney Transplantation", UNOS Region 2 Clinical Forum, Pittsburgh, PA. April 5, 2001.
"Nephron Dosing", International Transplant Nurses Society and the North American Transplant Coordinators Organization, Pittsburgh, PA. May 12, 2000.
"Post Transplant Neoplastic Diseases", Ho Chi Minh National Cancer Institute. March 13, 2000.
"The Selection of a Donor for Double Adult Kidney Transplant", UNOS Region 2 Transplant Meeting, Fairfax, VA. September 17, 1999.
"Optimizing Nephron Dosing", UNOS Region 2 Transplant Forum, Fairfax, VA. September 16, 1999.
Other presentations
"DIC and the Transplant Kidney Donor", Basic Research Conference, Allegheny General Hospital, Pittsburgh, PA. April 8, 2003.
"Sandostatin and Glucose Tolerance Post Pancreas Transplant", Basic Research Conference, Allegheny General Hospital, Pittsburgh, PA. April 8, 2003.
"The Abdomen Compartment Syndrome: Past, Present and Future", Surgical Grand Rounds, Allegheny General Hospital, Pittsburgh, PA. November 5, 2002.
"Ultrasound Evaluation of Renal Transplant Allograft", Allegheny General Hospital Research Day, Pittsburgh, PA. April 9, 2002.
"Double Adult Kidney Transplantation. A Physiologic Way to Optimize Organ Utilization", Surgical Grand Rounds, Allegheny General Hospital. Pittsburgh, PA. November 13, 2001.
"Effects of Pancreatic Exocrine Blockade on Endocrine Function", Basic Research Conference, Allegheny General Hospital, Pittsburgh, PA. July 20, 2000.
"Current Trends in Vascular Access", Surgical Grand Rounds, Allegheny General Hospital, Pittsburgh, PA. October 12, 1999.
"Current Trends in Immunosuppression", Surgical Grand Rounds, Allegheny General Hospital, Pittsburgh, PA. June 29, 1999.
> Back to Combined Faculty Listing
|